IGEA Pharma NV is a health-tech company focused on measure and control of test factors related to life-threatening diseases. It utilizes tests to measure Free Copper II in the blood stream, which is considered as one of the major modifiable risk factors of Alzheimer's disease and Diabetes Type II. The company was founded in 2015 and is headquartered in Hoofddorp, the Netherlands.
SIX